Investment
Features
FeesSafety
Academy
More
Pluang+

Insmed unveils new respiratory drug data at CHEST 2026 and IDWeek 2026 conferences

Market News
14 Oct 2026
PRNewsWire
View Source
Bullish
Insmed unveils new respiratory drug data at CHEST 2026 and IDWeek 2026 conferences

Insmed Incorporated announced new clinical data presentations for its respiratory drug portfolio at CHEST 2026 and IDWeek 2026, including insights on Treprostinil Palmitil Inhalation Powder (TPIP) for pulmonary hypertension and ARIKAYCE for Mycobacterium avium complex lung disease. The data highlight potential long-term benefits and resistance management, reinforcing Insmed's commitment to advancing treatments for serious lung diseases. These findings support ongoing development and regulatory efforts for these therapies.

Insmed's respiratory portfolio data presentations provide context for health sector activity on Pluang. For readers following health stocks, 103 out of 150 US health-sector stocks rose while 40 fell. Notable movers include Alcon AG at USD 64.17 with 100% buy orders, BioNano Genomics Inc at USD 1.39 with 98% sell orders, and AstraZeneca plc at USD 158.62 with 58% sell orders, as of Oct 14, 2026 18:11 WIB.

More News

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...

Others
Bullish
20 minutes ago
nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...

Market News
Bullish
20 minutes ago
ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...

Company Fundamentals
Bullish
1 hour ago
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...

Company Fundamentals
Bullish
1 hour ago
TSOs prioritize software investments to boost grid security and capacity amid rising demand

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App